Rein Therapeutics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell RNTX and other ETFs, options, and stocks.About RNTX
Rein Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of a novel class of therapeutics for the treatment of cancer and other diseases. It focuses on its lead product candidate, ALRN-6924, which is a cell-permeating peptide that disrupts the interaction of p53 suppressors MDM2 and MDMX with tumor suppressor p53 to reactivate tumor suppression in non-mutant, or wild-type, p53 cancers.
RNTX Key Statistics
Stock Snapshot
The current Rein Therapeutics(RNTX) stock price is $0.59, with a market capitalization of 50.13M. The stock trades at a price-to-earnings (P/E) ratio of -0.34.
On 2026-10-15, Rein Therapeutics(RNTX) stock moved within a range of $0.54 to $0.76. With shares now at $0.59, the stock is trading +9.4% above its intraday low and -21.7% below the session's peak.
Trading volume for Rein Therapeutics(RNTX) stock has reached 1.14M, versus its average volume of 473.89K.
The stock's 52-week range extends from a low of $0.54 to a high of $2.18.
The stock's 52-week range extends from a low of $0.54 to a high of $2.18.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.